ABSTRACT
BACKGROUND: Brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) have essential roles in synaptic plasticity which is involved in pathogenesis and treatment of psychiatric disorders. However, it is not clear whether they act simultaneously during illness states in major psychiatric disorders. METHODS: BDNF and GDNF serum levels were measured concomitantly by enzyme-linked immunosorbent assay (ELISA) method in 171 patients diagnosed with schizophrenia (n=33), bipolar disorder-manic episode (n=39), bipolar/unipolar depression (n=64, 24/40) and obsessive-compulsive disorder (n=35) according to DSM-IV, and 78 healthy volunteers. SCID-I and SCID non-patient version were used for clinical evaluation of the patients and healthy volunteers, respectively. Correlations between the two trophic factor levels, and illness severity scores, duration of illness and medication dosages were studied across different illnesses. RESULTS: While patients had equally lower BDNF levels in all diagnoses, GDNF levels were significantly higher in mania and lower in schizophrenia compared to healthy controls. BDNF levels were negatively correlated to illness severity scores in affective episodes (mania and depression). Longer duration of illness (>5 years) had an impact on lower GDNF levels in schizophrenia. BDNF levels and antipsychotic drug dosages in schizophrenia, and GDNF levels and antidepressant drug dosages in obsessive-compulsive disorder were positively correlated. CONCLUSION: Our data confirmed the evidence of equally deficient neuronal support by BDNF in all major psychiatric illnesses, but suggested a diverse glial functioning between schizophrenia and mania.
Subject(s)
Bipolar Disorder/blood , Depressive Disorder, Major/blood , Glial Cell Line-Derived Neurotrophic Factor/blood , Obsessive-Compulsive Disorder/blood , Schizophrenia/blood , Adult , Antipsychotic Agents/therapeutic use , Bipolar Disorder/physiopathology , Depressive Disorder, Major/physiopathology , Diagnostic and Statistical Manual of Mental Disorders , Female , Humans , Male , Middle Aged , Obsessive-Compulsive Disorder/physiopathology , Schizophrenia/physiopathology , Severity of Illness IndexABSTRACT
OBJECTIVE: The purpose of this study was to investigate the possibility of a differential sensitivity to CO2 in patients diagnosed with panic disorder subtypes that were defined by the presence of prominent respiratory symptoms. METHOD: The authors used a 35% CO2 and 65% O2 mixture as a challenge agent. Fifty-one unmedicated subjects with DSM-III-R panic disorder, who were divided into respiratory (N = 28) and nonrespiratory (N = 23) subtypes by their symptom profiles, underwent a CO2 challenge procedure. Patients in the two groups were compared with regard to physiological and psychological measures, pulmonary function tests, panic rates, and smoking habits. RESULTS: The patients in the respiratory group were significantly more sensitive to CO2 than were the patients in the nonrespiratory group. The respiratory group also had higher scores on the Panic and Agoraphobia Scale and had a longer duration of illness; both of these factors can be indicators of illness severity. In addition, the respiratory group's higher cigarette consumption (mean = 12.46 package-years, SD = 2.49) may have been a contributory factor not only for illness severity but also for the pathogenesis of panic disorder. CONCLUSIONS: The CO2 challenge procedure appears to be a good dissection tool in the understanding of different subtypes of panic disorder. Moreover, there may be a more specific association with prominent respiratory symptom subtype and CO2 hypersensitivity.
Subject(s)
Carbon Dioxide , Panic Disorder/chemically induced , Panic Disorder/diagnosis , Respiration Disorders/diagnosis , Administration, Inhalation , Adolescent , Adult , Age of Onset , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Panic Disorder/classification , Psychiatric Status Rating Scales , Respiration Disorders/chemically induced , Respiration Disorders/classification , Respiratory Function TestsSubject(s)
Kidney Failure, Chronic/psychology , Peritoneal Dialysis, Continuous Ambulatory/psychology , Renal Dialysis/psychology , Sexual Dysfunctions, Psychological/etiology , Adult , Affect/physiology , Aged , Chi-Square Distribution , Depression/psychology , Female , Humans , Kidney Failure, Chronic/therapy , Male , Middle Aged , Self Concept , Sexual Behavior/psychology , Sexual Dysfunction, Physiological/etiologyABSTRACT
Male pseudohermaphroditism (MPH), which causes ambiguous genitalia, rarely presents during adolescence. Herein we report two siblings diagnosed with MPH at the ages of 16 and 12 years and raised unambiguously as girls. Individuals with MPH provide caregivers the opportunity to observe the complex interaction between the biologic and psychosocial forces which shape gender identity. Factors which contribute to gender identity and the management of sex assignment may differ between cultures with regard to dominating sociocultural attitudes towards masculinity and femininity in a given society. The decision to perform feminizing surgery on both patients was made in consideration of these issues.
